Peter A. Harris

825 total citations
19 papers, 587 citations indexed

About

Peter A. Harris is a scholar working on Molecular Biology, Biotechnology and Genetics. According to data from OpenAlex, Peter A. Harris has authored 19 papers receiving a total of 587 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Molecular Biology, 6 papers in Biotechnology and 5 papers in Genetics. Recurrent topics in Peter A. Harris's work include Cancer Research and Treatments (6 papers), Virus-based gene therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Peter A. Harris is often cited by papers focused on Cancer Research and Treatments (6 papers), Virus-based gene therapy research (4 papers) and Cancer, Hypoxia, and Metabolism (4 papers). Peter A. Harris collaborates with scholars based in United Kingdom, Sweden and Latvia. Peter A. Harris's co-authors include Peter F. Searle, Folke Tjerneld, Gunnar Karlström, Daniel H. Palmer, Paul M. Loadman, Chris R. Dunk, Mark R. Albertella, Andrew Mountain, Lawrence S. Young and Jesse L. Clark and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Peter A. Harris

17 papers receiving 563 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Peter A. Harris United Kingdom 11 293 142 141 125 123 19 587
Joseph D. Mocanu Canada 14 365 1.2× 65 0.5× 162 1.1× 25 0.2× 160 1.3× 21 707
Dianne M. Ferry New Zealand 10 263 0.9× 55 0.4× 121 0.9× 89 0.7× 203 1.7× 12 562
Began Gopalan United States 17 516 1.8× 224 1.6× 267 1.9× 94 0.8× 64 0.5× 28 923
Sophie P. Syddall New Zealand 7 257 0.9× 108 0.8× 89 0.6× 146 1.2× 147 1.2× 12 438
Séverine Wack France 15 358 1.2× 69 0.5× 129 0.9× 67 0.5× 66 0.5× 16 673
Alan Bilsland United Kingdom 21 698 2.4× 190 1.3× 120 0.9× 138 1.1× 105 0.9× 37 988
Wenqi Jiang China 14 395 1.3× 60 0.4× 183 1.3× 87 0.7× 128 1.0× 22 796
Alexandra M. Mowday New Zealand 12 342 1.2× 117 0.8× 130 0.9× 203 1.6× 261 2.1× 22 766
Amir Ashoorzadeh New Zealand 11 241 0.8× 61 0.4× 65 0.5× 100 0.8× 149 1.2× 32 476
Mathew Robson United Kingdom 18 451 1.5× 79 0.6× 153 1.1× 41 0.3× 92 0.7× 30 901

Countries citing papers authored by Peter A. Harris

Since Specialization
Citations

This map shows the geographic impact of Peter A. Harris's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter A. Harris with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter A. Harris more than expected).

Fields of papers citing papers by Peter A. Harris

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Peter A. Harris. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter A. Harris. The network helps show where Peter A. Harris may publish in the future.

Co-authorship network of co-authors of Peter A. Harris

This figure shows the co-authorship network connecting the top 25 collaborators of Peter A. Harris. A scholar is included among the top collaborators of Peter A. Harris based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Peter A. Harris. Peter A. Harris is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Harris, Peter A., et al.. (2009). Pathogenesis of Pulmonary Hypertension. PubMed. 100(4). 62–80.
2.
Williams, Kaye J., Mark R. Albertella, Brian Fitzpatrick, et al.. (2009). In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts. Molecular Cancer Therapeutics. 8(12). 3266–3275. 38 indexed citations
3.
Albertella, Mark R., Paul M. Loadman, Philip H. Jones, et al.. (2008). Hypoxia-Selective Targeting by the Bioreductive Prodrug AQ4N in Patients with Solid Tumors: Results of a Phase I Study. Clinical Cancer Research. 14(4). 1096–1104. 98 indexed citations
4.
Ranson, Malcolm, Peter Hersey, Jane Beith, et al.. (2007). Randomized Trial of the Combination of Lomeguatrib and Temozolomide Compared With Temozolomide Alone in Chemotherapy Naive Patients With Metastatic Cutaneous Melanoma. Journal of Clinical Oncology. 25(18). 2540–2545. 76 indexed citations
5.
Albertella, Mark R., Paul M. Loadman, Kaye J. Williams, et al.. (2006). In vivo activation of the hypoxia-targeted cytotoxin AQ4N in human tumor xenografts. 66. 314–314. 6 indexed citations
6.
Albertella, Mark R., et al.. (2005). The novel hypoxia-targeted anticancer agent AQ4N is not subject to multi-drug resistance mediated by PGP/MDR1. Cancer Research. 65. 123–124. 1 indexed citations
7.
Green, Nicola K., Rachel Kerr, Vivien Mautner, Peter A. Harris, & Peter F. Searle. (2004). The Nitroreductase/CB1954 Enzyme-Prodrug System. Humana Press eBooks. 90. 459–478. 9 indexed citations
8.
Palmer, Daniel H., Vivien Mautner, Darius F. Mirza, et al.. (2004). Virus-Directed Enzyme Prodrug Therapy: Intratumoral Administration of a Replication-Deficient Adenovirus Encoding Nitroreductase to Patients With Resectable Liver Cancer. Journal of Clinical Oncology. 22(9). 1546–1552. 97 indexed citations
9.
10.
Harris, Peter A.. (2002). Metamorphosis of the Australasian income tax : 1866 to 1922. 217. 2 indexed citations
11.
Thomson, Tina, Hing Y. Leung, Peter F. Searle, et al.. (2001). Combined Adenovirus-Mediated Nitroreductase Gene Delivery and CB1954 Treatment: A Well-Tolerated Therapy for Established Solid Tumors. Molecular Therapy. 3(2). 233–240. 45 indexed citations
12.
Palmer, Daniel H., David A. Anderson, Jesse L. Clark, et al.. (2001). Virus-directed, enzyme prodrug therapy with nitroimidazole reductase: a phase I and pharmacokinetic study of its prodrug, CB1954.. PubMed. 7(9). 2662–8. 104 indexed citations
13.
Harris, Peter A.. (1996). Corporate/Shareholder income taxation and allocating taxing rights between countries : a comparison of imputation systems. Medical Entomology and Zoology. 10 indexed citations
14.
Harris, Peter A., Gunnar Karlström, & Folke Tjerneld. (1991). Enzyme purification using temperature-induced phase formation.. PubMed. 2(4). 237–46. 56 indexed citations
15.
Ferrari, Roberto, Gabriella Agnoletti, Anna Rodella, et al.. (1986). Release of factor neurotensin and bombesine from stretched rat atrium. Journal of Molecular and Cellular Cardiology. 18. 26–26. 1 indexed citations
16.
Harris, Peter A., Elizabeth S. Barrie, K Gibson, & J Gloster. (1975). Effects of chronic hypoxia on myocardial metabolism.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 8. 265–70. 1 indexed citations
17.
Harris, Peter A. & J Gloster. (1971). The Effects of Acute Hypoxia on Lipid Synthesis in the Rat Heart. Cardiology. 56(1-6). 43–47. 10 indexed citations
18.
Cumming, G., et al.. (1963). Frequency-dependent compliance at different levels of inspiration in normal adults. Journal of Applied Physiology. 18(6). 1061–1064. 22 indexed citations
19.
Bateman, Michael G., et al.. (1962). A comparison of the effect of acetylcholine and 100 per cent oxygen on the pulmonary circulation in patients withmitral stenosis.. PubMed. 22. 223–31. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Joseph D. Mocanu Breakdown of academic impact, for papers by Dianne M. Ferry Breakdown of academic impact, for papers by Began Gopalan Breakdown of academic impact, for papers by Sophie P. Syddall Breakdown of academic impact, for papers by Séverine Wack Breakdown of academic impact, for papers by Alan Bilsland Breakdown of academic impact, for papers by Wenqi Jiang Breakdown of academic impact, for papers by Alexandra M. Mowday Breakdown of academic impact, for papers by Amir Ashoorzadeh Breakdown of academic impact, for papers by Mathew Robson
Rankless by CCL
2026